Thursday, February 22, 2007

MedImmune v. Genentech: USPTO Issues Final Rejection in Reexamination

While the Supreme Court was deciding issues of standing, a good number of people wondered: "who needs standing when you have reexamination?"

Well the USPTO recently issued final rejections on Genentech's "Cabilly" patents (4,816,567 and 6,331,415). All of the claims of both patent were deemed invalid by the examiner.

Multiple 102 and 103 rejections were issued based on various prior art against the '567 patent. Also, all of the claims of the '415 patent were rejected on multiple non-statutory obviousness-type rejection based on the earlier ('567) patent, as well as other prior art.

Genentech has one more opportunity to respond to the rejections, and, if unsuccessful, will head to the BPAI on appeal.

  • To view the (consolidated) USPTO files for the '567 and '415 patent, click here.
  • Read yesterday's press release on the reexamination here.

Seja o primeiro a comentar

Powered By Blogger


This Blog/Web Site ("Blog") is for educational purposes only and is not legal advice. Use of the Blog does not create any attorney-client relationship between you and Peter Zura or his firm. Persons requiring legal advice should contact a licensed attorney in your state. Any comment posted on the Blog can be read by any Blog visitor; do not post confidential or sensitive information. Any links from another site to the Blog are beyond the control of Peter Zura and does not convey his, or his past or present employer(s) approval, support, endorsement or any relationship to any site or organization.

The 271 Patent Blog © 2008. Template by Dicas Blogger.